›› 2014, Vol. 29 ›› Issue (6): 685-687.DOI: 10.3969/j.issn.1673-8640.2014.06.025
Previous Articles Next Articles
Received:
2013-08-28
Online:
2014-06-30
Published:
2014-06-23
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2014.06.025
[1] Miki K,Morita M,Sasajima M,et al. Usefulness of gastric cancer screening using the serum pepsinogen test method[J] . Am J Gastroenterol,2003,98(4):735-739. [2] 程中华,熊文坚. 血清胃蛋白酶原检测在慢性萎缩性胃炎筛查中的价值[J] . 胃肠病学和肝病学杂志,2012,21(5):430-432. [3] 胡仁静,严子禾,沈洪远. 血清胃蛋白酶原在胃癌诊断中的价值[J] . 中国实验诊断学,2010,14(10):1650-1651. [4] 费凤英,王金金,祝新华,等. 血清胃蛋白酶原检测在胃部疾病诊断中的意义[J] . 检验医学,2012,27(1):57-59. [5] 卢灿荣,张士武,张 勇,等. 癌胚抗原、糖链抗原72-4和胃蛋白酶原联合检测评价胃癌的诊断价值[J] . 检验医学,2012,27(6):442-444. [6] 邬建民,张 力. 血清胃蛋白酶原、胃泌素-17和幽门螺杆菌IgG抗体对萎缩性胃炎的诊断价值[J] . 检验医学,2011,26(6):375-378. [7] 朱国民,邱 峰. 三种血清胃蛋白酶原检测方法在胃癌筛查中的比较分析[J] . 检验医学,2012,27(11):961-962. [8] 陈辉乐,金领微,毛朝鸣. 肾功能及血透对慢性肾脏疾病患者血清肿瘤标志物的影响[J] . 实用医学杂志,2008,24(4):552-554. [9] Murakawa M. Influence of impaired renal function and Helicobacter pylori on serum pepsinogen concentrations in dialysis patients[J] . Nephrol Dial Transplant, 1999,14(1): 113-117. [10] Ten Kate RW,Pals G,Pronk JC,et al. Renal handling of pepsinogens A and C in man[J] . Clin Sci(Lond),1988,75(6):649-654. [11] Nakahama H,Tanaka Y,Shirai D,et al. Elevated serum pepsinogens in chronic renal failure patients[J] . Nephron,1995,70(2):211-216. [12] Di Mario F,Moussa AM,Cavallaro LG,et al. Clinical usefulness of serum pepsinogen Ⅱ in the management of Helicobacter pylori infection[J] . Digestion,2004,70(3):167-172. [13] Aydemir S,Borazan A,Acikgoz S,et al. The effects of continuous ambulatory peritoneal dialysis and hemodialysis on serum pepsinogen concentrations in patients with chronic renal failure[J] . Tohoku J Exp Med, 2005, 205(3):263-268. [14] 徐巧莲,万小勇,杜 燕,等. 血清胃蛋白酶原检测在胃癌筛查中的价值[J] . 胃肠病学,2012,17(10): 614-617. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||